Indian roads can be chaotic, with dangerous stretches as well as reckless drivers. Any person involved in a road accident can ...
The 35th National Examination for Acupuncturists and Moxibustionists will be held on Sunday, February 28, 2027.Anatomy covers ...
For those suffering from a stiff neckI recently received a DM from an acquaintance. "What could they want?" I thought, and ...
Protected, High-Margin Medicines in the U.S., EXPAREL® and ZILRETTA®, and Expects to Expand the Products' Reach Across ...
What began as pain became "numbness and tingling, heaviness, weakness, swelling," and she began dropping things she was holding.
A rare case report describes bilateral acromion fractures in a five-week-old infant that were ultimately linked to congenital ...
Zacks Investment Research on MSN
PCRX expands Exparel commercial reach in Europe through Molteni deal
Pacira BioSciences PCRX announced an exclusive agreement with Molteni Farmaceutici to distribute and commercialize Exparel (bupivacaine liposome injectable suspension) in the EU and the United Kingdom ...
Blavity on MSN
Beyond back aches: How enlarged breasts are linked to chronic migraines, neck pain and sleep apnea
Enlarged breast tissue has long been seen as a purely esthetic or cosmetic issue and a condition that was misunderstood and ...
OrthoAtlanta, one of the Southeast’s largest physician-owned orthopedic and sports medicine practices, has appointed Daniel R. Lewis,... Read More ...
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, and Caregiver Action Network (CAN), ...
Viatris is acquiring Pacira BioSciences for $1.65 billion in cash, adding non-opioid pain therapies Exparel and Zilretta.
The finale of 'Four Hands, Two Sonatas' ends on a note that is gentler than the show's revenge-soaked middle stretch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results